|
Impact of the COVID-19 pandemic mitigation strategies on cancer treatment trials: A meta-analysis of industry and NCI studies. |
| |
|
Consulting or Advisory Role - AstraZeneca |
| |
|
Consulting or Advisory Role - Avalere Health |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
(OPTIONAL) Uncompensated Relationships - Society for Clinical Trials |
| |
|
No Relationships to Disclose |
| |
|
Employment - South Shore Hospital (I) |
Consulting or Advisory Role - N-Power Medicine |
| |
|
Consulting or Advisory Role - Bayer; Evidera/PPD; Genmab |
(OPTIONAL) Uncompensated Relationships - Eisai |
| |
|
Consulting or Advisory Role - AOC Oncology; AOC Oncology; AOC Oncology |
Other Relationship - Alliance Foundation Trials; Alphasights; AOC Oncology; Children's Hospital Los Angeles; George Washington University; University of Southern California |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |